Our experimental data and other studies above provide enough theoretical support and evidence for the molecular mechanism by which CKS2 induced EMT‐like process and tumorigenesis through activating TGFβ/SMAD signaling pathway in glioma. The gene discussed is CKS2; the disease is central nervous system cancer.